Skip to main content

Table 1 Characteristics of the patients with rheumatoid arthritis (n = 350)

From: Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis

Characteristics

 

P value

Age in years, mean ± SD

61.8 ± 11.8

< 0.001a

Female gender, number (percentage)

251 (71.7)

NSb

White-British race, number (percentage)

336 (96)

NSb

RF-positive, number (percentage)

238 (68)

NSb

Smoking status, number (percentage)

  

   Never smoked

157 (44.8)

NS

   Ex-smoker

133 (38)

 

   Current smoker

60 (17.2)

 

Pack-years, median (quartiles)

13.5 (5–30)

NSc

BMI in kg/m2, mean ± SD

27.1 ± 5.1

NSa

RA duration in years, median (quartiles)

10 (4–19)

0.01c

Disease activity (DAS28), mean ± SD

4.2 ± 1.37

NSa

CRP in mg/L, median (quartiles)

16.8 (5–20.7)

NSc

Hypertension, number (percentage)

256 (73.1)

0.008b

Systolic BP in mm Hg, mean ± SD

143.4 ± 20.9

0.002a

Diastolic BP in mm Hg, mean ± SD

78.9 ± 11.4

NSa

Total CHOL in mmol/L, mean ± SD

5.2 ± 1.2

0.018a

HDL CHOL in mmol/L, mean ± SD

1.6 ± 0.45

NSa

TG in mmol/L, median (quartiles)

1.43 (1–1.6)

0.001c

Diabetes mellitus, number (percentage)

25 (7.1)

NSb

HOMA IR, median (quartiles)

1.95 (1.2–3.3)

0.05c

QUICKI, mean ± SD

0.34 ± 0.04

0.05a

DMARDs, number (percentage)

303 (86.5)

NSb

MTX, number (percentage)

196 (56)

NSb

MTX dose in mg, median (quartiles)

10 (7.5–18.7)

NSc

Prednisolone, number (percentage)

110 (31.4)

NSb

Prednisolone dose in mg, median (quartiles)

7.5 (4.3–10)

NSc

NSAIDs, number (percentage)

68 (19.4)

NSb

COX-II inhibitors, number (percentage)

31 (8.8)

NSb

ACE inhibitors, number (percentage)

91 (26)

0.001b

Diuretics, number (percentage)

87 (24.8)

0.02b

Aspirin, number (percentage)

57 (16.2)

NSb

  1. P values represent the significance of the association with glomerular filtration rate. The symbols after P values show the corresponding statistical test: afor Pearson correlation, bfor t test and cfor Spearman correlation. ACE: angiotensin-converting enzyme; BMI: body mass index; BP: blood pressure; CHOL: cholesterol; COX-II: cycloxygenase II; CRP: C-reactive protein; DAS28: disease activity score using 28 joint counts; DMARD: disease-modifying antirheumatic drug; HDL: high-density lipoprotein; HOMA IR: homeostasis model assessment of insulin resistance; MTX: methotrexate; NS: nonsignificant; NSAID: nonsteroidal anti-inflammatory drug; QUICKI: quantitative insulin sensitivity check index; RA: rheumatoid arthritis; RF: rheumatoid factor; SD: standard deviation; TG: triglycerides.